viernes, 6 de noviembre de 2009

IMS: Cambia de dueño...

NORWALK, Conn. November 5, 2009 (AP)

.../...

The company, based in Norwalk, Conn., said the deal is valued at $5.2 billion including the assumption of debt.

The announcement comes after weeks of speculation following media reports in October that the company was on the auction block. On Oct. 20, the company said it is exploring a variety of strategic alternatives, but did not mention the possibility of a sale. A day prior to that, media reports prompted speculation that the company could be sold to a private equity firm, potentially garnering a 30 percent premium. (Ver...)


Ha sido adquirida por
TPG Capital:



TPG Capital is the global buyout group of TPG, a leading private investment firm founded in 1992 with approximately $45 billion of assets under management and offices in San Francisco, London, Hong Kong, New York, Fort Worth, Washington, D.C., Melbourne, Moscow, Mumbai, Paris, Luxembourg, Beijing, Shanghai, Singapore and Tokyo. TPG Capital has extensive experience with global public and private investments executed through leveraged buyouts, recapitalizations, spinouts, joint ventures and restructurings. TPG Capital’s healthcare investments have included Axcan Pharma, Biomet, Fenwal, IASIS Healthcare, Quintiles Transnational, and Surgical Care Affiliates, among others. TPG’s technology investments have included SunGard, Fidelity National Information Services, Sabre Holdings, Aptina, Avaya, and Intergraph, among others.


y por CPP:



The CPP Investment Board is a professional investment management organization that invests the funds not needed by the Canada Pension Plan to pay current benefits on behalf of 17 million Canadian contributors and beneficiaries.

1 comentario:

Hector dijo...

Es curioso el imperio que puede construir una empresa con una actividad que raya en la ética y legalidad.
Recuerdo que PMA (IMS Health de Argentina) vendía sus famosos informes sobre las ventas de productos de sus clientes, información que "teoricamente" obtenía de intercambios de información en la industria, pero que en realidad eran obtenidos de acuerdos con farmacias que les "prestaban" copias de las prescripciones médicas en lugares estratégicos de la ciudad, algo que podría infringir el derecho a la privacidad en muchos paises.
Con esta información se elaboraban informes y gráficas muy bonitas, con mapas y colores, y también servía para poder presionar a los médicos que habían asistido al seminario en Cancún y estaban prescribiendo producto de la competencia.
Evidentemente hay cosas que a pesar de la ética y la privacidad seguirán siendo negocio...